Viking Therapeutics, Inc.
VKTXNasdaqCIK 1607678HealthcareFiscal year ends Dec 31
Reports and events: 182 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2817:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-405580 |
| 2026-09-2207:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-397219 |
| 2026-07-2917:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-324219 |
| 2026-07-2916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323652 |
| 2026-05-2616:48 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-239535 |
| 2026-04-3021:50 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-193315 |
| 2026-04-2916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-191487 |
| 2026-04-0116:14 ET | DEF 14A | Proxy statementPeriod 2026-05-19 | 0001193125-26-137915 |
| 2026-02-1117:25 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-046876 |
| 2026-02-1116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-046536 |
| 2025-10-2317:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-247059 |
| 2025-10-2216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-246775 |
| 2025-08-1907:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607678-25-000003 |
| 2025-07-2317:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-097950 |
| 2025-07-2316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-097885 |
| 2025-05-2717:20 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-077865 |
| 2025-04-2416:37 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-058129 |
| 2025-04-2316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-057337 |
| 2025-04-2316:01 ET | 8-K | 4.01 Change of auditor; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-057323 |
| 2025-04-0817:03 ET | DEF 14A | Proxy statementPeriod 2025-05-20 | 0000950170-25-052162 |
| 2025-03-1107:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-036820 |
| 2025-02-2616:32 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027824 |
| 2025-02-0516:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-014464 |
| 2024-11-0406:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-120267 |
| 2024-10-2317:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-116708 |
| 2024-10-2316:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-116642 |
| 2024-07-2417:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-086111 |
| 2024-07-2416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-086039 |
| 2024-06-0407:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-068297 |
| 2024-05-2319:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-063707 |
| 2024-04-2520:42 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-047833 |
| 2024-04-2416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-047567 |
| 2024-04-0516:05 ET | DEF 14A | Proxy statementPeriod 2024-05-21 | 0000950170-24-042251 |
| 2024-03-2607:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-036151 |
| 2024-03-0416:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-024878 |
| 2024-03-0116:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-023838 |
| 2024-02-2707:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-020616 |
| 2024-02-0717:24 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-012322 |
| 2024-02-0716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-012199 |
| 2023-10-2517:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-055259 |
| 2023-10-2516:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-055209 |
| 2023-07-2616:46 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-034773 |
| 2023-07-2616:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-034741 |
| 2023-06-1416:23 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-23-027965 |
| 2023-05-1117:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-23-021359 |
| 2023-05-0116:01 ET | DEF 14A | Proxy statement | 0000950170-23-016221 |
| 2023-04-2617:01 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-014883 |
| 2023-04-2616:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-014788 |
| 2023-04-0317:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-011636 |
| 2023-03-3117:27 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-011443 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.